The current study was designed to investigate the effects of 1-(1,3-benzodioxol-5-yl-carbonyl) piperidine (1-BCP) on swimming endurance capacity which as one indicator of fatigue in the weight-loaded forced swimming mice. Mice were given either vehicle or 1-BCP (0.1, or 0.2 mmol/kg body weight daily) by intraperitoneal injection once daily for 2 weeks. The 1-BCP groups showed a significant increase in swimming time to exhaustion compared with the control group. 1-BCP increased the liver glycogen (LG) and muscle glycogen (MG) contents significantly, while decreased the lactic acid (LA) and blood urea nitrogen (BUN) levels notably compared with control group. Besides, 1-BCP treatment also significantly improved the endogenous cellular antioxidant enzymes in mice by increasing the activities of superoxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GSH-Px). Therefore, this study demonstrated for the first time that the supplementation of 1-BCP, as a positive allosteric modulator of α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor, could enhance the endurance capacity of mice and facilitated them recovery from fatigue. Thus, we provide a new effective therapeutic strategy for fatigue.Key words 1-(1,3-benzodioxol-5-yl-carbonyl) piperidine; fatigue; endurance capacity; weight-loaded forced swimming; α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor modulator Fatigue is best defined as the difficulties in initiating or sustaining voluntary activities, and can be classified into mental and physical subcategories. Fatigue is usually accompanied by deterioration in performance, which is resulted from several stress and hard physical or mental work.1,2) It is one of the most frequent symptoms and most disabling nonmotor problems in the modern society and would generate severe negative consequences on cognition, physical performance function, and quality of life in patients with the Parkinson's disease.3) Unfortunately, there have not been few medications to treat fatigue, and the current therapeutic stategies for relieving fatigue have not been effective enough.3)Persons at risk for impaired performance and health-related issues resulting from fatigue would benefit from agents capable of reducing these detrimental effects during they are fatigue. These agents could produce anti-fatigue effects by supplying energy substances, accelerating the elimination of metabolic products, adjusting the internal environment, enhancing body immunity or directly stimulating the nervous system. 4) A series of alertness-enhancing compounds that have been utilized to combat the fatigue, including methamphetamine, amphetamine, caffeine, and modafinil. However, a number of literatures reported their side effects, such as the potential to addiction and potent stimulant actions, which can distort cognitive and sensory processes at doses required to counteract the effects of fatigue. 5,6) In addition, selective serotonin reuptake inhibitors have been utilized to treat chronic fatigue syndrome. The...